Part III. Developmental disorders, alternative approaches, and emerging technologies.
出版信息
Handb Exp Pharmacol. 2015;228:305-7.
PMID:26317141
Abstract
摘要
相似文献
1
Part III. Developmental disorders, alternative approaches, and emerging technologies.
Handb Exp Pharmacol. 2015;228:305-7.
2
3
Verbal memory.言语记忆。
Handb Exp Pharmacol. 2015;228:237-47. doi: 10.1007/978-3-319-16522-6_8.
4
Part 1. Basic approaches and perspectives.第一部分. 基本方法与观点。
Handb Exp Pharmacol. 2015;228:1-3.
5
Correspondence on ''the unrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production''.关于“未被识别的癫痫谱系：左乙拉西坦对与亚临床棘波产生相关的神经心理功能的影响”的通信
J Child Neurol. 2009 Dec;24(12):1578; author reply 1579. doi: 10.1177/0883073809347800.
6
Experts urge smart thinking on cognitive enhancers.专家敦促对认知增强剂进行明智思考。
Lancet Neurol. 2008 Jun;7(6):476-7. doi: 10.1016/S1474-4422(08)70101-7.
7
Preface to cognitive enhancement.认知增强前言。
Handb Exp Pharmacol. 2015;228:v.
8
Memory and menopause: an unsolved puzzle.记忆与更年期：一个未解之谜。
Aging (Albany NY). 2018 Oct 15;10(10):2541-2543. doi: 10.18632/aging.101596.
9
Drugs for cognitive loss and dementia.用于认知功能减退和痴呆的药物。
Treat Guidel Med Lett. 2010 Mar;8(91):19-24.
10
Declarative memory.陈述性记忆。
Handb Exp Pharmacol. 2015;228:215-36. doi: 10.1007/978-3-319-16522-6_7.
Zotero 插件